A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis
Mingsheng Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Liying Cui(Ansteel (China)), Xusheng Huang(Chinese PLA General Hospital), Huifang Shang(Sichuan University), Xiaoli Yao(Second Military Medical University), Dongsheng Fan(Peking University), Jia He(Shanghai University of Medicine and Health Sciences)
Cited by 3
Related Papers
Endoplasmic reticulum stress‐induced exosomal miR‐27a‐3p promotes immune escape in breast cancer via regulating PD‐L1 expression in macrophages
|Journal of Cellular and Molecular Medicine|2020|204
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia
|Alzheimer s Research & Therapy|2021|200
Parkinson's disease in the Western Pacific Region
|The Lancet Neurology|2019|193
The role of genetics in Parkinson’s disease: a large cohort study in Chinese mainland population
|Brain|2020|167
Toward cleaner production: What drives farmers to adopt eco-friendly agricultural production?
|Journal of Cleaner Production|2018|164